| 1. |
鄭姬, 府偉靈, 張曉兵. 尿路感染常見病原菌的分布及耐藥性分析. 中華醫院感染學雜志, 2007, 17(5):1294-1296.
|
| 2. |
李光輝. 尿路感染的診斷與治療. 中國抗感染化療雜志, 2001, 1(1):58-60.
|
| 3. |
蔡煥榮. 876株尿培養的細菌分布及耐藥性分析. 海南醫學, 2011, 22(4):110-112.
|
| 4. |
陳慧莉, 陶傳敏, 陳知行, 等. 1998-2001年尿培養病原菌變遷及耐藥性分析. 華西醫學, 2002, 17(4):526-527.
|
| 5. |
Eshwarappa M, Dosegowda R, Aprameya IV, et al. Clinicomicrobiological profile of urinary tract infection in south India. Indian J Nephrol, 2011, 21(1):30-36.
|
| 6. |
趙群益, 胡宏平, 許小敏. 潔尿培養病原菌分布及耐藥監測324例分析. 實用醫學雜志, 2009, 25(8):1319-1320.
|
| 7. |
Calbo E, Romaní V, Xercavins M, et al. Risk factors for communityonset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother, 2006, 57(4):780-783.
|
| 8. |
Azap OK, Arslan H, Serefhano?lu K, et al. Risk factors for extendedspectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect, 2010, 16(2):147-151.
|
| 9. |
Mava Y, Ambe JP, Bello M, et al. Evaluation of the nitrite test in screening for urinary tract infection in febrile children with sickle cell anaemia in Maiduguri-Nigeria. Niger Med J, 2011, 52(1):45-48.
|
| 10. |
張騰飛, 陳劍芳, 周毛嬰. 妊娠期尿路感染危險因素的臨床研究. 中國全科醫學, 2012, 15(12):3984-3986.
|
| 11. |
Emiru T, Beyene G, Tsegaye W, et al. Associated risk factors of urinary tract infection among pregnant women at Felege Hiwot Referral Hospital, Bahir Dar, North West Ethiopia. BMC Res Notes, 2013, 6:292.
|
| 12. |
Mendelson G, Hait V, Ben-Israel J, et al. Prevalence and risk factors of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis, 2005, 24(1):17-22.
|
| 13. |
Muvunyi CM, Masaisa F, Bayingana C, et al. Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda:need for new antimicrobial guidelines. Am J Trop Med Hyg, 2011, 84(6):923-928.
|
| 14. |
李真, 戴麗, 張亞蓮, 等. 下呼吸道感染產超廣譜β-內酰胺酶革蘭陰性菌耐藥性分析及臨床意義. 中華醫院感染學雜志, 2002, 12(1):13-15.
|
| 15. |
黃瑞娟, 葉臨湘, 馮啟明. 大腸埃希菌產超廣譜β-內酰胺酶的危險因素研究. 疾病控制雜志, 2008, 12(2):141-143.
|
| 16. |
陳科帆, 馮秀娟, 呂曉菊, 等. 70例產超廣譜β-內酰胺酶大腸埃希菌尿路感染臨床分析. 中國抗生素雜志, 2011, 36(12):939-942.
|
| 17. |
喬廬東, 陳山, 孟黎輝, 等. 產ESBLs大腸埃希菌尿路感染的危險因素分析. 中華醫院感染學雜志, 2011, 21(2):247-249.
|
| 18. |
湯春波, 齊勇. Cox比例風險模型分析ESBLs大腸埃希菌致尿路感染危險因素. 中華全科醫學, 2014, 12(3):397-399.
|